Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0T5OW
|
|||
| Former ID |
DNC014079
|
|||
| Drug Name |
2-(4-(4-Hydroxyphenyl)thiazol-2-ylamino)phenol
|
|||
| Synonyms |
CHEMBL551839; 2-(4-(4-Hydroxyphenyl)thiazol-2-ylamino)phenol
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H12N2O2S
|
|||
| Canonical SMILES |
C1=CC=C(C(=C1)NC2=NC(=CS2)C3=CC=C(C=C3)O)O
|
|||
| InChI |
1S/C15H12N2O2S/c18-11-7-5-10(6-8-11)13-9-20-15(17-13)16-12-3-1-2-4-14(12)19/h1-9,18-19H,(H,16,17)
|
|||
| InChIKey |
HXSHJTRADFDFMA-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fructose-1,6-bisphosphatase (FBP) | Target Info | Inhibitor | [1] |
| BioCyc | Gluconeogenesis | |||
| KEGG Pathway | Glycolysis / Gluconeogenesis | |||
| Pentose phosphate pathway | ||||
| Fructose and mannose metabolism | ||||
| Metabolic pathways | ||||
| Biosynthesis of antibiotics | ||||
| Carbon metabolism | ||||
| AMPK signaling pathway | ||||
| Insulin signaling pathway | ||||
| Glucagon signaling pathway | ||||
| Pathwhiz Pathway | Fructose and Mannose Degradation | |||
| Pentose Phosphate Pathway | ||||
| Gluconeogenesis | ||||
| Reactome | Gluconeogenesis | |||
| WikiPathways | Glycolysis and Gluconeogenesis | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A library of novel allosteric inhibitors against fructose 1,6-bisphosphatase. Bioorg Med Chem. 2009 Jun 1;17(11):3916-22. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.